| 偏头痛治疗曙光初现5-HT1B/1D受体激动剂的临床应用 |
| |
| 引用本文： | 张石革,马国辉. 偏头痛治疗曙光初现5-HT1B/1D受体激动剂的临床应用[J]. 中国处方药, 2004, 0(2): 54-58 |
| |
| 作者姓名： | 张石革 马国辉 |
| |
| 作者单位： | 1. 北京大学第四临床医学院
2. 北京积水潭医院 |
| |
| 摘 要： | OBJECTIVE:Migraine is a common and frequently-occurring disease in neuromedicine.with understading of mechanism of migraine,new anti-migraine drugs have been found constantly to summarize the aspect of clinical application and progress on 5-HT1B/1D receptor agonist(Triptan).METHODS: To collecte medical literatures in recent years at home and abroad.CONCLUSION:Advance in 5-HT1B/1D receptor agonist has been swiftly in recent years, it has higher selectivity to 5-HT1B/1D receptor, contraction of cerebral vessel and arteriae temporalis, efficacy being related to dosage, promoting distribution of blood flow,so 5-HT1B/1D receptor agonist(triptan) plays an important roles in treatment of migraine.
|
| 关 键 词： | 偏头痛 治疗 受体激动剂 家族史 阿莫曲普坦 |
Clinical application of 5-HT1B/1D receptor agonist(triptan) to the treatment of migraine--a ray of sunlight |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
